Coronary vasomotion dysfunction after everolimus-eluting stent implantation

First generation drug-eluting stent can cause a paradoxical “in-segment” coronary vasoconstriction. This phenomenon was seen with sirolimus, paclitaxel, and, more recently, also with zotarolimus-eluting stent. For the first time, we describe a case of coronary-induced vasoconstriction by everolimus-...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Interv Med Appl Sci
Egile Nagusiak: Giudice, Pietro, Attisano, Tiziana, Di Maio, Marco, Bellino, Elisabetta M., Polito, Maria V., Baldi, Cesare, Vigorito, Francesco, Di Muro, Michele R., Tomasello, Salvatore D., Galassi, Alfredo R., Piscione, Federico
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Akadémiai Kiadó 2014
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4274358/
https://ncbi.nlm.nih.gov/pubmed/25598992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1556/IMAS.6.2014.4.6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak